Market Value1,658,443,000
Total Holdings55
File Date2022-02-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
STSA / Satsuma Pharmaceuticals Inc
INRLF / Valneva SE
ELEV / Elevation Oncology, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
IOBT / IO Biotech, Inc.
DSGN / Design Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
CMPX / Compass Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
SVA / Sinovac Biotech, Ltd.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
SNDX / Syndax Pharmaceuticals, Inc.
AADI / Aadi Bioscience, Inc.
ALGS / Aligos Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
SERA / Sera Prognostics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
PASG / Passage Bio, Inc.
ISEE / IVERIC bio Inc
ALXO / ALX Oncology Holdings Inc.
ZGNX / Zogenix Inc
COGT / Cogent Biosciences, Inc.
AVDL / Avadel Pharmaceuticals plc
CRNX / Crinetics Pharmaceuticals, Inc.
RLMD / Relmada Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
DICE / DICE Therapeutics Inc
TXG / 10x Genomics, Inc.
SRRA / Sierra Oncology Inc
BLU / Bellus Health Inc
AUPH / Aurinia Pharmaceuticals Inc.
KDNY / Chinook Therapeutics Inc
LRMR / Larimar Therapeutics, Inc.
MTCR / Metacrine Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
FIXX / Homology Medicines, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
CDXS / Codexis, Inc.
NKTX / Nkarta, Inc.
NFH / New Frontier Health Corporation - Class A
CLDX / Celldex Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
BOLT / Bolt Biotherapeutics, Inc.
UTRS / Minerva Surgical, Inc.
KURA / Kura Oncology, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
KDMN / Kadmon Holdings Inc
MRUS / Merus N.V.
TCDA / Tricida Inc
CRIS / Curis, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
TIL / Instil Bio, Inc.
DYN / Dyne Therapeutics, Inc.
AMRS / Amyris Inc
DTIL / Precision BioSciences, Inc.
IMPL / Impel Pharmaceuticals Inc.